Policy
Liver disease linked to obesity and high blood sugar could affect 1.8bn people worldwide by 2050, a study suggests. Metabolic dysfunction-associated steatotic liver disease, or MASLD, was previously known as non-alcoholic fatty liver disease. It is one of the most common and fastest-growing liver conditions worldwide. There are now 1.3bn people worldwide living with MASLD, [...]
A prebiotic fibre supplement may ease arthritis pain and improve grip strength in people with knee osteoarthritis, a study suggests. The daily supplement, made from inulin, a dietary fibre found in chicory root, Jerusalem artichokes and other vegetables, also lowered pain sensitivity and saw fewer people drop out than a digital physiotherapy programme tested alongside [...]
The Scottish Medicines Consortium has declined to recommend the Alzheimer's therapy donanemab (Kisunla, Eli Lilly) for early-stage disease in NHS Scotland. The decision affects patients with mild cognitive impairment and mild dementia caused by Alzheimer's disease who are apolipoprotein E epsilon 4 heterozygotes or non-carriers, a genetic marker. The consortium cited uncertainty over clinical relevance [...]









